These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 33172223)

  • 1. Severe, Symptomatic Reinfection in a Patient with COVID-19.
    Selvaraj V; Herman K; Dapaah-Afriyie K
    R I Med J (2013); 2020 Nov; 103(10):24-26. PubMed ID: 33172223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covid-19 antibody tests: a briefing.
    Baraniuk C
    BMJ; 2020 Jun; 369():m2284. PubMed ID: 32580937
    [No Abstract]   [Full Text] [Related]  

  • 3. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.
    Goetz L; Yang J; Greene W; Zhu Y
    J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic.
    Stavert R; Meydani-Korb A; de Leon D; Osgood R; Blau J; Luu T
    J Am Acad Dermatol; 2020 Dec; 83(6):1753-1755. PubMed ID: 32822790
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid roll out of SARS-CoV-2 antibody testing-a concern.
    Andersson M; Low N; French N; Greenhalgh T; Jeffery K; Brent A; Ball J; Pollock A; McCoy D; Iturriza-Gomara M; Buchan I; Salisbury H; Pillay D; Irving W
    BMJ; 2020 Jun; 369():m2420. PubMed ID: 32580928
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 serologic testing: FAQs and caveats.
    Kadkhoda K
    Cleve Clin J Med; 2020 Jun; 87(6):329-333. PubMed ID: 32434807
    [No Abstract]   [Full Text] [Related]  

  • 7. Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS-CoV-2/COVID-19.
    Patel R; Babady E; Theel ES; Storch GA; Pinsky BA; St George K; Smith TC; Bertuzzi S
    mBio; 2020 Mar; 11(2):. PubMed ID: 32217609
    [No Abstract]   [Full Text] [Related]  

  • 8. Will antibody tests for the coronavirus really change everything?
    Mallapaty S
    Nature; 2020 Apr; 580(7805):571-572. PubMed ID: 32313159
    [No Abstract]   [Full Text] [Related]  

  • 9. Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients.
    Yu HQ; Sun BQ; Fang ZF; Zhao JC; Liu XY; Li YM; Sun XZ; Liang HF; Zhong B; Huang ZF; Zheng PY; Tian LF; Qu HQ; Liu DC; Wang EY; Xiao XJ; Li SY; Ye F; Guan L; Hu DS; Hakonarson H; Liu ZG; Zhong NS
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32398307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based ELISA for Detecting SARS-CoV-2 IgG.
    Antoine-Reid T; Malone J; Maris AS; White-Abell J; Schmitz JE
    J Appl Lab Med; 2020 Nov; 5(6):1416-1420. PubMed ID: 32750140
    [No Abstract]   [Full Text] [Related]  

  • 11. The COVID-19 Pandemic in the US: A Clinical Update.
    Omer SB; Malani P; Del Rio C
    JAMA; 2020 May; 323(18):1767-1768. PubMed ID: 32250388
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid roll out of SARS-CoV-2 antibody testing: even at high levels of specificity, an important proportion of test results will be false positives.
    Gruer L; Bhopal R
    BMJ; 2020 Jul; 370():m2910. PubMed ID: 32699002
    [No Abstract]   [Full Text] [Related]  

  • 13. Is reinfection possible after recovery from COVID-19?
    Law SK; Leung AWN; Xu C
    Hong Kong Med J; 2020 Jun; 26(3):264-265. PubMed ID: 32536614
    [No Abstract]   [Full Text] [Related]  

  • 14. How deadly is the coronavirus? Scientists are close to an answer.
    Mallapaty S
    Nature; 2020 Jun; 582(7813):467-468. PubMed ID: 32546810
    [No Abstract]   [Full Text] [Related]  

  • 15. The Detection of Novel Coronavirus Antibodies is an Important Supplementary Detection Method for Screening of High-Risk Population.
    Wang D; Jia X; Huang T; Wang H; Li S; Ren T; Nie H; Chen Z; Song C; Zhou Y; Ma W; Shen H
    Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658430
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronavirus Disease 2019 Test Results After Clinical Recovery and Hospital Discharge Among Patients in China.
    Wu J; Liu X; Liu J; Liao H; Long S; Zhou N; Wu P
    JAMA Netw Open; 2020 May; 3(5):e209759. PubMed ID: 32442288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The explosion of new coronavirus tests that could help to end the pandemic.
    Guglielmi G
    Nature; 2020 Jul; 583(7817):506-509. PubMed ID: 32681157
    [No Abstract]   [Full Text] [Related]  

  • 18. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
    Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041
    [No Abstract]   [Full Text] [Related]  

  • 19. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Jun; 16(696):1174-1175. PubMed ID: 32496708
    [No Abstract]   [Full Text] [Related]  

  • 20. Selecting a SARS-CoV-2/COVID Molecular Testing Method for Your Laboratory.
    Greene DN
    J Appl Lab Med; 2020 Jul; 5(4):837-840. PubMed ID: 32761155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.